Aktie 4557 MEDICAL & BIOLOGICAL LABORATORIES CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Medical & Biological Laboratories Co., Ltd.

Aktien

4557

JP3131450003

4557

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Crown Bioscience and MBL Enter Joint Venture to Provide Advanced Preclinical Services for Japanese Customers
JSR Corporation acquired remaining 7.27% stake in Medical & Biological Laboratories Co., Ltd. for ¥1.7 billion.
JSR Corporation completed the acquisition of an additional 41.91% stake in Medical & Biological Laboratories Co., Ltd. for ¥9.5 billion.
JSR Corporation made an offer to acquire the remaining 49.2% stake in Medical & Biological Laboratories Co., Ltd. for ¥11.2 billion.
Medical & Biological Laboratories Co., Ltd. Starts the Sale of A Test Kit (For Research Use Only) for Measuring SARS-CoV-2 Neutralizing Antibodies
Medical & Biological Laboratories Co., Ltd. Announces “MEBRIGHTTM SARS-CoV-2 Kit” Was Approved with Marketing Authorization in Japan for the Detection of Novel Coronavirus “SARS-CoV-2”
Medical and Biological Laboratories Co., Ltd. Concludes License Agreement with China National Biotec Group Co., Ltd
Medical & Biological Laboratories Co., Ltd. Launches New ELISA-Based Companion Diagnostic Kit for Spinal Muscular Atrophy
Pmt Corporation Co. Ltd. cancelled the acquisition of Lifetech Co., Ltd from Medical & Biological Laboratories Co., Ltd. and others.
MEDICAL & BIOLOGICAL LABORATORIES Co., Ltd. Enters into Collaboration Agreement with the p53 Laboratory
Pmt Corporation Co. Ltd. agreed to acquire Lifetech Co., Ltd from Medical & Biological Laboratories Co., Ltd. and others for ¥0.07 million.
MBL International Corporation announced that it has received funding from JSR Micro, Inc., Medical & Biological Laboratories Co., Ltd.
MBL International Corporation announced that it expects to receive funding from JSR Micro, Inc., Medical & Biological Laboratories Co., Ltd.
Chiome Bioscience Inc. acquired remaining 47.1% stake in LivTech Inc. from Medical & Biological Laboratories Co., Ltd., KSP Inc., Kouji Nakamura, Hiroyuki Yanai and 3 other individuals.
JSR Corporation completed the acquisition of 13.88% stake in Medical & Biological Laboratories Co., Ltd. for ¥2.2 billion.
JSR Corporation offered a take overbid to acquire 17.9% stake in Medical & Biological Laboratories Co., Ltd. for ¥2.8 billion.
Medical & Biological Laboratories, Co., Ltd. Opens MBL Europe Office in Diegem, Belgium
Medical & Biological Laboratories Co., Ltd. cancelled the acquisition of histopathology examination businesses of Histo Science Laboratory Co., Ltd.
Medical & Biological Laboratories Co., Ltd. cancelled the acquisition of remaining 91.3% stake in ACTGen, Inc. from Toshieki Kajikawa and other shareholders.
Closed Merger/Acquisition Transaction – Target: LivTech Inc.; Buyer(s): Chiome Bioscience Inc.; Seller(s): JAFCO Incubation No. 2 Venture Capital Investment Limited Partnership, KSP Inc., MBL Venture Capital Co., Ltd., Medical & Biological Laboratories Co., Ltd., ReqMed Venture Capital, Yokohama Capital Co. Ltd.; Transaction Size: ¥87.75 mm
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 4557 Aktie
  4. Nachrichten Medical & Biological Laboratories Co., Ltd.
  5. Andere Sprachen